* Comments and Likes are appreciated *
What I see...
+ Contrary to a mid-March slump like 99% of stocks, Clorox spiked up and quickly retraced to form an inverted 'v' shape in a week
+ Prices have been slowly creeping up to test the $200 range and retrested
+ It broke above $200 last week painted multiple NR3 bars
+ Friday's bar was a NR7 and NR3 combo! with retracting vol.
+ MACD is bullish
+ RSI is closing in on over-bought territory at 66
- Prices got pulled far away from 10MA
- Long upper shadow formed from mid-March's spike, well into the $210 territory
- RSI is at 66
- Narrow range bars last week all had upper shadows
What I setup...
+ Long entry above $206
- Stop at low of channel
+ Target at 618 Fib
:: I may keep this one longer than 1 week
What I see...
+ Contrary to a mid-March slump like 99% of stocks, Clorox spiked up and quickly retraced to form an inverted 'v' shape in a week
+ Prices have been slowly creeping up to test the $200 range and retrested
+ It broke above $200 last week painted multiple NR3 bars
+ Friday's bar was a NR7 and NR3 combo! with retracting vol.
+ MACD is bullish
+ RSI is closing in on over-bought territory at 66
- Prices got pulled far away from 10MA
- Long upper shadow formed from mid-March's spike, well into the $210 territory
- RSI is at 66
- Narrow range bars last week all had upper shadows
What I setup...
+ Long entry above $206
- Stop at low of channel
+ Target at 618 Fib
:: I may keep this one longer than 1 week
Trade active
Long entry triggeredTrade active
Moved Stop to 203.88Trade closed: stop reached
Stopped out today; -0.38R
Shake Shake Leg
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Shake Shake Leg
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.